Richard Broadhead
About Richard Broadhead
Richard Broadhead is a Field Application Scientist at Precision NanoSystems, Inc. in Oxford, UK, where he has worked since 2016. He has a background in molecular biology and has contributed to research in nanomedicine and vaccine development.
Work at Precision NanoSystems
Richard Broadhead has served as a Field Application Scientist at Precision NanoSystems, Inc. since 2016. Based in Oxford, UK, he focuses on facilitating the development of novel nanomedicines and advanced vaccines and therapeutics. His work encompasses areas such as immuno-oncology, rare diseases, and infectious diseases. Broadhead has played a significant role in establishing and applying the company's NanoAssemblr and NxGen technology for medical nanoparticle production across Europe. He actively engages with current technology users and seeks to expand the user base while exploring new applications for the company's technology.
Education and Expertise
Richard Broadhead holds a PhD from the University of Aberdeen, which he completed from 1994 to 1998. He also earned a BSc (Hons) from the University of Birmingham, studying from 1991 to 1994. His educational background provides a strong foundation for his expertise in the field of nanomedicine and molecular biology. Broadhead's extensive knowledge is further demonstrated by his first authorship on a paper published in Nature, highlighting his research capabilities.
Background
Before joining Precision NanoSystems, Richard Broadhead accumulated a diverse work history. He was a Postdoctoral Research Scientist at Lancaster University from 2002 to 2006. He also held various roles in sales and technical positions, including Technical Sales Representative at Invitrogen, Technical Sales Manager, and Sales and Marketing Manager at Oxford Expression Technologies. Additionally, he worked as a Product Specialist in Molecular Biology at Alpha Laboratories Ltd from 2012 to 2016. His early career included a position as Assistant Manager at Oddbins from 1998 to 2000.
Achievements
Richard Broadhead has made notable contributions to the field of nanomedicine and molecular biology. He is recognized as the first author of a paper published in Nature, which underscores his research excellence. His leadership in establishing Precision NanoSystems' technology for nanoparticle production has been instrumental in advancing medical applications across Europe. Broadhead's role in expanding the user base and exploring novel applications for the company's technology reflects his commitment to innovation in the industry.